Hailong Yang

Title: Hailong Yang: Innovator in Pharmaceutical Chemistry

Introduction

Hailong Yang is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new methods for drug preparation. His innovative work has led to the creation of a patented method that enhances the formulation of a critical medication.

Latest Patents

Hailong Yang holds a patent for "Crystalline forms of temozolomide and the method for preparing same." This invention provides a new method for preparing crystalline forms of Temozolomide, which is essential for treating certain types of cancer. The method involves dissolving Temozolomide in dimethyl sulphoxide and adding a second organic solvent for recrystallization. This process results in three distinct crystalline forms of Temozolomide, utilizing solvents such as alcohols, ketones, halohydrocarbons, or esters.

Career Highlights

Hailong Yang is associated with Jiangsu Tasly Diyi Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical development. His work has not only advanced the understanding of Temozolomide but has also contributed to the broader field of drug formulation and delivery.

Collaborations

Hailong Yang collaborates with esteemed colleagues, including Guocheng Wang and Wenzheng Liu. Their combined efforts in research and development have fostered innovation within their organization and the pharmaceutical industry.

Conclusion

Hailong Yang's contributions to pharmaceutical chemistry, particularly through his patent on Temozolomide, highlight his role as an innovator in the field. His work continues to impact the development of effective cancer treatments.